Evidence map›Paper›PMID 37987145›Full record

ArticleJournal of cellular and molecular medicine2024

N-n-butyl haloperidol iodide mediates cardioprotection via regulating AMPK/FoxO1 signalling.

Binger Lu, Zhuomin Wu, Weiliang He, Zikai Feng, Jilin Liao, Bin Wang, Yanmei Zhang, Fenfei Gao, Ganggang Shi, Fuchun Zheng

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of cellular and molecular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Binger LuThe First Affiliated Hospital, Shantou University Medical College, Shantou, China.ORCID 0000-0001-7724-9232
Zhuomin WuThe First Affiliated Hospital, Shantou University Medical College, Shantou, China.
Weiliang HeDepartment of Pharmacology, Shantou University Medical College, Shantou, China.
Zikai FengThe First Affiliated Hospital, Shantou University Medical College, Shantou, China.
Jilin LiaoThe Second Affiliated Hospital, Shantou University Medical College, Shantou, China.
Bin WangDepartment of Pharmacology, Shantou University Medical College, Shantou, China.
Yanmei ZhangDepartment of Pharmacology, Shantou University Medical College, Shantou, China.
Fenfei GaoDepartment of Pharmacology, Shantou University Medical College, Shantou, China.
Ganggang ShiDepartment of Pharmacology, Shantou University Medical College, Shantou, China.
Fuchun ZhengDepartment of Pharmacology, Shantou University Medical College, Shantou, China.
Shantou University · CN

Funding

National Natural Science Foundation of China 81870276National Natural Science Foundation of China 81903613
6 · The paper itself

Abstract

Derangement of redox condition largely contributes to cardiac ischemia/reperfusion (I/R) injury. FoxO1 is a transcription factor which transcripts a series of antioxidants to antagonize I/R-induced oxidative myocardial damage. N-n-butyl haloperidol iodide (F

Indexed as

AMP-Activated Protein KinasesReperfusion InjuryAnimalsAntioxidantsHaloperidolMiceMyocardiumSignal TransductionAMP-Activated Protein KinasesAntioxidantsHaloperidolN-n-butyl haloperidol iodideAMPKcardioprotectionFoxO1ischemia reperfusionN-n-butyl haloperidol iodideoxidative stress

Identifiers

PMID37987145
PMCPMC10826434
OpenAlexW4388869528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.